Article
RUNX1 mutation has no prognostic significance in paediatric AML: A retrospective study of the AML-BFM study group
2022-12-29
Abstract excerpt
<title>Abstract</title> <p>In acute myeloid leukaemia (AML) <italic>RUNX1</italic> mutation is characterized by certain clinicopathological features with poor prognosis and adverse risk by the European LeukemiaNet recommendation. Though initially considered as provisional category, the recent World Health Organization (WHO) classification of 2022 removed <italic>RUNX1</italic>-mutated AML from the unique entity....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0b3f52ca-1a14-504a-b247-d7b95b8c97d2
- DOI
- 10.21203/rs.3.rs-2378701/v1
